Multidisciplinary Project Award
About this scheme
Applications should ideally include:
- a minimum of two PIs working in distinct scientific disciplines
- at least one PI working in cancer research at any career stage
- at least one PI from an engineering/physical science discipline at any career stage
Applications will be accepted from UK universities, research institutions, Cancer Research UK core-funded Institutes, medical schools and hospitals. The award is not required to be co-located and can be held across institutions in the UK, supporting roles from international and commercial organisations may also be included.
If you are unsure of your eligibility, please contact the office.
The aim of these awards is to generate creative research ideas and explore their applicability in cancer research. These awards are awarded jointly between Principal Investigators (PI) from engineering/physical science disciplines, and PIs who are working in cancer research.
With a primary focus on multidisciplinary research, the research themes within remit for this award include:
- The direct application of physics, engineering, chemical or mathematical concepts to address the underlying physical processes of cancer, including tumour initiation, growth and metastasis.
- The development of new transformational approaches or the translation of technologies for direct applications in, or a clear path to, a direct application in the prevention, diagnosis or treatment of cancer. Proposals for the first applications of technologies in cancer research and those which demonstrate potential clinical applicability are encouraged.
In addition, we welcome proposals across all engineering and physical science disciplines including physics, engineering, mathematical and computational modelling, chemical and molecular sciences, materials science, molecular/tissue engineering and regenerative medicine. For more specific details of research supported by Multidisciplinary Project Awards, please refer to the scheme guidelines.
Multidisciplinary Project Awards are designed to fund individual project proposals, for research proposals of a similar nature that encompass a more detailed body of work, please refer to the Programme Awards.
Applications will be judged based on how well the project proposal meets the following criteria:
- Scientific excellence and innovation
- Cancer relevance and importance to furthering the understanding of cancer or potential benefits to cancer patients
- Feasibility, added value and individual contributions of the collaboration
Funding support provided for:
- Postdoctoral researchers
- PhD students (stipend, fees and running expenses)
- Technical staff
- Associated running expenses
How to apply to this scheme
Overview of the application process
Applications for Multidisciplinary Project Awards are considered twice a year and follow a two-stage process:
- A short project outline must be uploaded to our electronic Grants Management System (eGMS). An example outline form (docx) is provided to help you prepare your outline application. Outline applications will be considered by the Multidisciplinary Expert Review Panel.
- Full applications will be invited from successfull outline applicants to be submitted to our eGMS. These will be peer-reviewed by international experts in the field, before review by the Multidisciplinary Expert Review Panel and a final funding decision made by the Science Committee.
Outline application deadline
Full application deadline
25 January 2017
16 May 2017
All full applications must be made through our electronic Grants Management System (eGMS), where one PI must assume the responsibility of named Lead Applicant.
Before you begin your application
Cancer Research UK contact details
Related guidance to download
Mathematician Dr John MacKenzie and molecular biologist Professor Robert Insall have teamed up to take a novel approach to understanding cell migration. Find out how their complementary skills and clear clinical direction convinced the committee that they had a great multidisciplinary project.
We're driving collaboration and strengthening networking as multidisciplinary team science becomes ever more essential to beating cancer.